Publication: Trimethylamine N-oxide and kidney diseases: what do we know?
Program
KU-Authors
KU Authors
Co-Authors
Gungor O, Alaygut D.
Editor & Affiliation
Compiler & Affiliation
Translator
Other Contributor
Date
Language
Type
Embargo Status
Journal Title
Journal ISSN
Volume Title
Alternative Title
Abstract
In the human gut, there is a metabolically active microbiome whose metabolic products reach various organs and are used in the physiological activities of the body. When dysbiosis of intestinal microbial homeostasis occurs, pathogenic metabolites may increase and one of them is trimethyl amine-N-oxide (TMAO). TMAO is thought to have a role in the pathogenesis of insulin resistance, diabetes, hyperlipidemia, atherosclerotic heart diseases, and cerebrovascular events. TMAO level is also associated with renal inflammation, fibrosis, acute kidney injury, diabetic kidney disease, and chronic kidney disease. In this review, the effect of TMAO on various kidney diseases is discussed.
Source
Publisher
Soc Brasileira Nefrologia
Subject
Medicine
Citation
Has Part
Source
J Bras Nefrol
Book Series Title
Edition
DOI
10.1590/2175-8239-JBN-2023-0065en